TRADITIONAL CHINESE MEDICIN EXTRACT, MEDICAMENT, AND DETECTION METHOD THEREFOR
老挝专利「TRADITIONAL CHINESE MEDICIN EXTRACT, MEDICAMENT, AND DETECTION METHOD THEREFOR」是 DIP 公开可查的知识产权档案，由 JIANGSU KANION PHARMACEUTICAL CO., LTD 于 2023-03-15 提交申请，当前状态为已注册。关键编号与类型标注为 申请号 P/1004 / DIP 编号 LAP1004 / 主管局代码 LA / 保护类型 Patent - PCT National Phase。时间线要点：公开/公告日 2026-06-05；授权日 2026-06-03；届满/失效参考日 2043-03-15。国际分类 / IPC 标注为 G01N 30/02、G01N 30/86、A61K 33/06、A61P 11/00、A61P 31/14、A61P 31/16、A61K 36/9068。发明人 / 设计人包括 LIU, Lina ZHOU, Enli XIAO, Wei WANG, Tuanjie WANG, Zhenzhong YU, Guifang HU, Hanfei CAO, Liang LI, Liang ZHANG, Chenfeng YAN, Ming。代理机构 / 代理人记载为 Ageless Lao Sole Co., Ltd.。公开摘要提示：The disclosure relates to a Traditional Chinese Medicine extract, wherein, by weight ratio, the extract is made from the following ingredie…。
This Laos Patent “TRADITIONAL CHINESE MEDICINE EXTRACT, MEDICAMENT, AND DETECTION METHOD THEREFOR” is a public DIP intellectual-property record, filed by JIANGSU KANION PHARMACEUTICAL CO., LTD on 2023-03-15; current status: Registered. Identifiers include application No. P/1004; DIP id LAP1004; protection kind Patent - PCT National Phase. Key dates: publication 2026-06-05; grant 2026-06-03; expiry reference 2043-03-15. Classification: G01N 30/02、G01N 30/86、A61K 33/06、A61P 11/00、A61P 31/14、A61P 31/16、A61K 36/9068. Inventor(s)/designer(s): LIU, Lina ZHOU, Enli XIAO, Wei WANG, Tuanjie WANG, Zhenzhong YU, Guifang HU, Hanfei CAO, Liang LI, Liang ZHANG, Chenfeng YAN, Ming. Abstract hint: The disclosure relates to a Traditional Chinese Medicine extract, wherein, by weight ratio, the extract is made from the following ingredie…. This prose is informational only and does not constitute legal advice, ownership proof or an infringement opinion.
ໜ້ານີ້ສະຫຼຸບ ສິດທິບັດ «TRADITIONAL CHINESE MEDICIN EXTRACT, MEDICAMENT, AND DETECTION METHOD THEREFOR» ຈາກຂໍ້ມູນຈົດທະບຽນເປີດ, ຍື່ນໂດຍ JIANGSU KANION PHARMACEUTICAL CO., LTD ໃນວັນທີ 2023-03-15; ສະຖານະ ຈົດທະບຽນແລ້ວ. ຕົວລະບຸ: ເລກທີຄຳຮ້ອງ P/1004; ລະຫັດ DIP LAP1004; ປະເພດການປົກປ້ອງ Patent - PCT National Phase. ວັນທີສຳຄັນ: ວັນເຜີຍແຜ່ 2026-06-05; ວັນຈົດທະບຽນ/ອະນຸຍາດ 2026-06-03; ວັນໝົດອາຍຸ 2043-03-15. ປະເພດ/ຫ້ອງ: G01N 30/02、G01N 30/86、A61K 33/06、A61P 11/00、A61P 31/14、A61P 31/16、A61K 36/9068. ນັກປະດິດ/ນັກອອກແບບ: LIU, Lina ZHOU, Enli XIAO, Wei WANG, Tuanjie WANG, Zhenzhong YU, Guifang HU, Hanfei CAO, Liang LI, Liang ZHANG, Chenfeng YAN, Ming. ສະຫຼຸບ: The disclosure relates to a Traditional Chinese Medicine extract, wherein, by weight ratio, the extract is made from the following ingredie…. ຂໍ້ຄວາມນີ້ເນັ້ນຕົວເລກ, ວັນທີ, ປະເພດ ແລະ ຜູ້ຍື່ນ ເພື່ອຫຼຸດຄວາມຄ້າຍຄືນລະຫວ່າງໜ້າ IP; ກວດຂໍ້ມູນທາງການກ່ອນຕັດສິນໃຈ.
P/1004
图样
基础信息
- 类型
- 专利
- 申请号
P/1004- 状态
- 已注册
- 申请人
- JIANGSU KANION PHARMACEUTICAL CO., LTD
- 代理机构
- Ageless Lao Sole Co., Ltd.
- 申请日期
- 2023-03-15
- 注册号
P/1004- 公开/公告日
- 2026-06-05
- 注册/授权日
- 2026-06-03
- 届满日
- 2043-03-15
- 国际分类
- G01N 30/02 · G01N 30/86 · A61K 33/06 · A61P 11/00 · A61P 31/14 · A61P 31/16 · A61K 36/9068
- 商品 / 服务
- —
办理流程
根据当前状态动态标注-
提交申请
-
形式审查
-
实质审查
-
公开
-
授权
关联分析
LaoBiz 企业数据库联动类似专利推荐
摘要
The disclosure relates to a Traditional Chinese Medicine extract, wherein, by weight ratio, the extract is made from the following ingredients: Magnoliae Officinalis Cortex 1-100 parts, Arecae Semen 1-100 parts, Amomum tsaoko Crevost & Lem. 1-100 parts, Ephedrae Herba 1-100 parts, Armeniacae Semen Amarum 1-100 parts, Notopterygii Rhizoma et Radix 1-100 parts, Zingiberis Rhizoma 1-100 parts, Pogostemonis Herba 1-100 parts, Eupatorium fortunei Turcz. 1-100 parts, Atractylodis Rhizoma 1-100 parts, Poria cocos 1-100 parts, Atractylodis Macrocephalae Rhizoma 1-100 parts, Gypsum Fibrosum 1-100 parts, Crataegi Fructus 1-100 parts, Massa Medicata Fermentata 1-100 parts, Hordei Fructus Germinatus 1-100 parts, Pheretima 1-100 parts, Vincetoxicum pycnostelma Kitag. 1-100 parts, Dryopteridis Crassirhizomatis Rhizoma 1-100 parts, and Lepidium apetalum seeds 1-100 parts; wherein, the extract has an ephedrine content of 0.5-1.5 mg/g and a solid content transfer rate of 18-25%.
The disclosure relates to a Traditional Chinese Medicine extract, wherein, by weight ratio, the extract is made from the following ingredients: Magnoliae Officinalis Cortex 1-100 parts, Arecae Semen 1-100 parts, Amomum tsaoko Crevost & Lem. 1-100 parts, Ephedrae Herba 1-100 parts, Armeniacae Semen Amarum 1-100 parts, Notopterygii Rhizoma et Radix 1-100 parts, Zingiberis Rhizoma 1-100 parts, Pogostemonis Herba 1-100 parts, Eupatorium fortunei Turcz. 1-100 parts, Atractylodis Rhizoma 1-100 parts, Poria cocos 1-100 parts, Atractylodis Macrocephalae Rhizoma 1-100 parts, Gypsum Fibrosum 1-100 parts, Crataegi Fructus 1-100 parts, Massa Medicata Fermentata 1-100 parts, Hordei Fructus Germinatus 1-100 parts, Pheretima 1-100 parts, Vincetoxicum pycnostelma Kitag. 1-100 parts, Dryopteridis Crassirhizomatis Rhizoma 1-100 parts, and Lepidium apetalum seeds 1-100 parts; wherein, the extract has an ephedrine content of 0.5-1.5 mg/g and a solid content transfer rate of 18-25%.